Retrospective cost analysis of management of febrile neutropenia in cancer patients in Spain

By Mayordomo José Ignacio   López Andrés   Viñolas Núria   Castellanos Javier   Pernas Sonia   Domingo Alonso Juan   Frau Adolfo   Layola Miquel   Antonio Gasquet José   Sánchez Jordi  

Current Medical Research and Opinion, Vol. 25, Iss. 10, 2009-10 ,pp. : 2533-2542

Informa Healthcare

Access to resources Recommend Favorite

Burden of febrile neutropenia in the Netherlands

By  

EUROPEAN JOURNAL OF CANCER CARE (ELECTRONIC), Vol. 24, Iss. 2, 2015-03 ,pp. : 232-241

John Wiley & Sons Inc

Access to resources Recommend Favorite

Clinical Outcomes and Cost‐effectiveness of Primary Prophylaxis of Febrile Neutropenia During Adjuvant Docetaxel and Cyclophosphamide Chemotherapy for Breast Cancer

By  

THE BREAST JOURNAL, Vol. 21, Iss. 6, 2015-11 ,pp. : 658-664

John Wiley & Sons Inc

Access to resources Recommend Favorite

Incidence and Predictors of Febrile Neutropenia among Early-Stage Breast Cancer Patients Receiving Anthracycline-Based Chemotherapy in Korea

By  

Oncology, Vol. 91, Iss. 5, 2016-09 ,pp. : 274-282

Karger

Access to resources Recommend Favorite

Predicting bacterial infections among pediatric cancer patients with febrile neutropenia: External validation of the PICNICC model

By  

PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol. 65, Iss. 4, 2018-04 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite